Report overview
This report contains market size and forecasts of Soft Tissue Sarcoma Drugs in Global, including the following market information:
Global Soft Tissue Sarcoma Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Soft Tissue Sarcoma Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Local Sarcoma Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Soft Tissue Sarcoma Drugs include Roche, Pfizer, Johnson & Johnson, GSK Plc, Teva Pharmaceuticals, Celgene, Bristol Myers Squibb, BeiGene and Shenzhen Chipscreen, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Soft Tissue Sarcoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Soft Tissue Sarcoma Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Soft Tissue Sarcoma Drugs Market Segment Percentages, by Type, 2022 (%)
Local Sarcoma
Metastatic Sarcoma
Other Sarcoma
Global Soft Tissue Sarcoma Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Soft Tissue Sarcoma Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Oncology Centers
Other
Global Soft Tissue Sarcoma Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Soft Tissue Sarcoma Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Soft Tissue Sarcoma Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Soft Tissue Sarcoma Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Pfizer
Johnson & Johnson
GSK Plc
Teva Pharmaceuticals
Celgene
Bristol Myers Squibb
BeiGene
Shenzhen Chipscreen
Monopar Therapeutics
Akeso Biopharma
